Related references
Note: Only part of the references are listed.Fibroblast growth factor 21: from pharmacology to physiology
Steven A. Kliewer et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2010)
Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State
Ffolliott M. Fisher et al.
DIABETES (2010)
Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease
Yusuf Yilmaz et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2010)
Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease
Jody Dushay et al.
GASTROENTEROLOGY (2010)
Thyroid Hormone Regulates Hepatic Expression of Fibroblast Growth Factor 21 in a PPARα-dependent Manner
Andrew C. Adams et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Regulation of FGF21 Expression and Secretion by Retinoic Acid Receptor-related Orphan Receptor α
Yongjun Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride
Huating Li et al.
JOURNAL OF HEPATOLOGY (2010)
The Effect of a Plant-Based Low-Carbohydrate (Eco-Atkins) Diet on Body Weight and Blood Lipid Concentrations in Hyperlipidemic Subjects
David J. A. Jenkins et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity
M. Mraz et al.
CLINICAL ENDOCRINOLOGY (2009)
Circulating Fibroblast Growth Factor-21 Is Elevated in Impaired Glucose Tolerance and Type 2 Diabetes and Correlates With Muscle and Hepatic Insulin Resistance
Alberto O. Chavez et al.
DIABETES CARE (2009)
Fibroblast Growth Factor 21-Deficient Mice Demonstrate Impaired Adaptation to Ketosis
Michael K. Badman et al.
ENDOCRINOLOGY (2009)
Fibroblast Growth Factor 21 Reduces the Severity of Cerulein-Induced Pancreatitis in Mice
Charis L. Johnson et al.
GASTROENTEROLOGY (2009)
Different Roles of N- and C-Termini in the Functional Activity of FGF21
Radmila Micanovic et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Circulating Fibroblast Growth Factor 21 Is Induced by Peroxisome Proliferator-Activated Receptor Agonists But Not Ketosis in Man
Constantinos Christodoulides et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
PGC-1α negatively regulates hepatic FGF21 expression by modulating the heme/Rev-Erbα axis
Jennifer L. Estall et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
FGF21 induces PGC-1α and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response
Matthew J. Potthoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARα activation in man
Cecilia Gaelman et al.
CELL METABOLISM (2008)
Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans
Xinmei Zhang et al.
DIABETES (2008)
Plasma FGF-21 levels in type 2 diabetic patients with ketosis
Ling Li et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
Fibroblast Growth Factor 21 Corrects Obesity in Mice
Tamer Coskun et al.
ENDOCRINOLOGY (2008)
FGF21 is an Akt-regulated myokine
Yasuhiro Izumiya et al.
FEBS LETTERS (2008)
FGF-21/FGF-21 receptor interaction and activation is determined by βKlotho
Alexei Kharitonenkov et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa
Ivana Dostalova et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Mini-review: Endocrine actions of fibroblast growth factor 19
Stacey Jones
MOLECULAR PHARMACEUTICS (2008)
Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor γ and altered metabolic states
Eric S. Muise et al.
MOLECULAR PHARMACOLOGY (2008)
Identification of a domain within peroxisome proliferator-activated receptor gamma regulating expression of a group of genes containing fibroblast growth factor 21 that are selectively repressed by SIRT1 in adipocytes
Hong Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Circulating FGF-21 levels in normal subjects and in newly diagnose patients with type 2 diabetes Mellitus
W. -W. Chen et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2008)
PPARα is a key regulator of hepatic FGF21
Thomas Lundasen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Hepatic fibroblast growth factor 21 is regulated by PPARα and is a key mediator of hepatic lipid metabolism in ketotic states
Michael K. Badman et al.
CELL METABOLISM (2007)
A high-fat, ketogenic diet induces a unique metabolic state in mice
Adam R. Kennedy et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Endocrine regulation of the fasting response by PPARα-mediated induction of fibroblast growth factor 21
Takeshi Inagaki et al.
CELL METABOLISM (2007)
βKlotho is required for metabolic activity of fibroblast growth factor 21
Yasushi Ogawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members
Regina Goetz et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women
Christopher D. Gardner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Molecular determinants of FGF-21 activity-synergy and cross-talk with PPAR gamma signaling
Julie S. Moyers et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Asymptomatic carnitine depletion on ketogenic diet in patients with pharmacoresistant epilepsies
G. Liebhaber et al.
KLINISCHE PADIATRIE (2006)
FGF-21 as a novel metabolic regulator
A Kharitonenkov et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Comparison of the Atkins, Ornish, Weight watchers, and Zone diets for weight loss and heart disease risk reduction
ML Dansinger et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
The crystal structure of fibroblast growth factor (FGF) 19 reveals novel features of the FGF family and offers a structural basis for its unusual receptor affinity
NJ Harmer et al.
BIOCHEMISTRY (2004)
Peripherally administered [Nle4,D-Phe7]-α-melanocyte stimulating hormone increases resting metabolic rate, while peripheral agouti-related protein has no effect, in wild type C57BL/6 and ob/ob mice
N Hoggard et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2004)
A randomized trial of a low-carbohydrate diet for obesity
GD Foster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A low-carbohydrate as compared with a low-fat diet in severe obesity
FF Samaha et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Chronic CNS administration of Agouti-related protein (Agrp) reduces energy expenditure
CJ Small et al.
INTERNATIONAL JOURNAL OF OBESITY (2003)
Molecular cloning and expression analyses of mouse ßklotho, which encodes a novel Klotho family protein
S Ito et al.
MECHANISMS OF DEVELOPMENT (2000)
Defect in peroxisome proliferator-activated receptor α-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting
T Hashimoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Identification of a novel FGF, FGF-21, preferentially expressed in the liver
T Nishimura et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2000)
Share Paper
